Indegene
PublicIndegene is now publicly traded
The data on this page reflects Indegene's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
May 3, 2024
Est. Valuation at Exit
$1.29B
Total Funding Raised
$273M
Company Overview
Indegene is a life sciences company that offers digital-led commercialization services, supporting biopharmaceutical, biotech, and medical device firms with drug development, regulatory submissions, and sales and marketing efforts.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
Indegene Comparables
Compare Indegene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Real Chemistry | 85% | |
| Inizio | 85% | |
| Trinity Life Sciences | 84% |
Indegene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | May 3, 2024 | ||||
| Private Equity | Feb 3, 2021 | ||||
| VC Round | Sep 17, 2005 |
Indegene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Citigroup Global Markets India | Private Placement |
| Axis Asset Management Company | Private Placement |
| Edelweiss Asset Management Limited | Private Placement |
| Brighton Park Capital | Private Equity |
| Loomis, Sayles & Company | Private Placement |
| The Carlyle Group | Private Equity |
| Fidelity Investments | Private Placement |
Indegene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access